Literature DB >> 15837453

Enhancing adherence in clinical research.

William N Robiner1.   

Abstract

This article presents overviews of adherence or compliance in clinical care and research, focusing on the need to enhance research adherence. The scope of the clinical research enterprise and costs of conducting clinical research are summarized. Costs associated with suboptimal adherence in clinical care and research also are addressed, along with their implications for enhancing adherence. Methodological problems and statistical challenges (including intent-to-treat) associated with poor adherence are reviewed. Addressing social factors, regimen characteristics, behavioral patterns, and systems issues can affect adherence. Strategies for enhancing adherence in clinical research subjects, including pre-randomization screening, behavioral and educational interventions, monitoring, and enhancing subjects' status and contingencies for adhering are discussed. Integrating adherence-enhancing strategies throughout research phases, from pre-randomization screening during recruitment to endpoint, has the potential to improve the quality and outcome of research while limiting costs.

Mesh:

Year:  2005        PMID: 15837453     DOI: 10.1016/j.cct.2004.11.015

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  41 in total

1.  A model to transfer trial-based pharmacoeconomic analyses to clinical practice.

Authors:  Afschin Gandjour
Journal:  Pharmacoeconomics       Date:  2011-02       Impact factor: 4.981

2.  Autobiography of William N. Robiner, Ph.D.

Authors:  William N Robiner
Journal:  J Clin Psychol Med Settings       Date:  2017-03

3.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

4.  Adherence and renal biopsy feasibility in the Renin Angiotensin-System Study (RASS) primary prevention diabetes trial.

Authors:  William N Robiner; Trudy D Strand; Michael Mauer
Journal:  Diabetes Res Clin Pract       Date:  2013-09-17       Impact factor: 5.602

5.  Development and preliminary results of the Financial Incentive Coercion Assessment questionnaire.

Authors:  Margaret M Byrne; Jason R Croft; Michael T French; Karen L Dugosh; David S Festinger
Journal:  J Subst Abuse Treat       Date:  2011-11-23

Review 6.  The effect of physical exercise strategies on weight loss in postpartum women: a systematic review and meta-analysis.

Authors:  S L Nascimento; J Pudwell; F G Surita; K B Adamo; G N Smith
Journal:  Int J Obes (Lond)       Date:  2013-09-19       Impact factor: 5.095

Review 7.  Understanding the quality chasm for hypertension control in diabetes: a structured review of "co-maneuvers" used in clinical trials.

Authors:  Aanand D Naik; Tim T Issac; Richard L Street; Mark E Kunik
Journal:  J Am Board Fam Med       Date:  2007 Sep-Oct       Impact factor: 2.657

8.  Desirability and feasibility of wireless electronic monitoring of medications in clinical trials.

Authors:  William N Robiner; Nancy Flaherty; Thyra A Fossum; Thomas E Nevins
Journal:  Transl Behav Med       Date:  2015-09       Impact factor: 3.046

9.  Understanding compliance issues for daily self-injectable treatment in ambulatory care settings.

Authors:  Meryl Brod; Matthew Rousculp; Ann Cameron
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

Review 10.  Adherence and its measurement in phase 2/3 microbicide trials.

Authors:  Elizabeth E Tolley; Polly F Harrison; Els Goetghebeur; Kathleen Morrow; Robert Pool; Doug Taylor; Stephanie N Tillman; Ariane van der Straten
Journal:  AIDS Behav       Date:  2010-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.